Helmet Noninvasive Ventilation of COVID-19 Patients
Helmet Noninvasive Ventilation of COVID-19 Patients
Noninvasive ventilation (NIV) may help COVID-19 patients in respiratory failure avoid invasive mechanical ventilation but may also lead to delays in intubation with potential for worse clinical outcomes.Domenico L. Grieco, MD of Fondazione Policlinico Agostino Gemelli IRCCS in Rome
Jesse B. Hall, MD of @UChicagoMedicine, and
Laveena Munshi, MD, MSc of @UHNToronto
join JAMA's live Q&A series to discuss a trial comparing helmet NIV vs high-flow nasal oxygen (HFNO) for management of hypoxic coronavirus patients. Recorded March 25, 2021.
Topics discussed in this interview:
0:00 Introduction
1:12 Trial overview
4:55 Enthusiasm for helmet noninvasive ventilation
6:23 Dr Hall's reactions to the study
8:30 Was this study difficult to conduct?
11:24 Implications of this study
13:37 Does this study move the dial for using helmets?
15:48 What was the neurologic status of the patients?
17:40 Proning NIV patients
20:38 Tidal volume
23:47 Have the results changed your practice?
25:33 What does the future look like for this technology?
29:18 Designing a larger trial
30:50 Final words on the trial
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.